Itahashi Motoki, Higaki Shiro, Shimomura Yoshikazu
Department of Ophthalmology, Kinki University School of Medicine, Osaka-Sayama, Japan.
Semin Ophthalmol. 2008 Jul-Aug;23(4):241-7. doi: 10.1080/08820530802111291.
To compare the efficacies of valacyclovir (VCV) and acyclovir (ACV) on murine herpetic epithelial keratitis, mice inoculated with herpes simplex virus type 1(HSV-1) strain McKrae were divided into 6 treatment groups: oral VCV 50 mg/kg and 100 mg/kg, oral ACV 50 mg/kg, ACV eye ointment (EO), ACV eye drops (ED), and placebo. Keratitis scores showed that oral VCV 50 mg/kg, oral ACV, and ACV ED had equivalent efficacies, while oral VCV 100 mg/kg was as efficacious as ACV EO during acute infection. Each treatment group was further divided into the stimulated group with HSV-1 reactivation by immunosuppressant drugs and hyperthermia, and the non-stimulated group without reactivation. We assessed the virus titers in tissues by plaque assay and HSV DNA copy number in the trigeminal ganglia (TG) by real time polymerase chain reaction (PCR). Results showed that the virus titers in the tissues were lowered after reactivation, and the oral VCV group with reactivation had significantly reduced DNA copy number in the TG than the same treatment group without reactivation. In conclusion, oral VCV is as efficacious as ACV EO and significantly suppresses HSV-1 reactivation.
为比较伐昔洛韦(VCV)和阿昔洛韦(ACV)对小鼠疱疹性上皮性角膜炎的疗效,将接种1型单纯疱疹病毒(HSV-1)McKrae株的小鼠分为6个治疗组:口服50mg/kg和100mg/kg的VCV、口服50mg/kg的ACV、ACV眼膏(EO)、ACV滴眼液(ED)和安慰剂。角膜炎评分显示,口服50mg/kg的VCV、口服ACV和ACV滴眼液疗效相当,而在急性感染期间,口服100mg/kg的VCV与ACV眼膏疗效相同。每个治疗组进一步分为通过免疫抑制药物和热疗使HSV-1重新激活的刺激组和未重新激活的非刺激组。我们通过噬斑测定法评估组织中的病毒滴度,并通过实时聚合酶链反应(PCR)评估三叉神经节(TG)中的HSV DNA拷贝数。结果显示,重新激活后组织中的病毒滴度降低,且重新激活的口服VCV组TG中的DNA拷贝数比未重新激活的同一治疗组显著减少。总之,口服VCV与ACV眼膏疗效相同,并能显著抑制HSV-1重新激活。